Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.

Kaushansky A, Gordus A, Budnik BA, Lane WS, Rush J, MacBeath G.

Chem Biol. 2008 Aug 25;15(8):808-17. doi: 10.1016/j.chembiol.2008.07.006.

2.

Phosphotyrosine interactome of the ErbB-receptor kinase family.

Schulze WX, Deng L, Mann M.

Mol Syst Biol. 2005;1:2005.0008.

3.

The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.

Wilson KJ, Mill CP, Gallo RM, Cameron EM, VanBrocklin H, Settleman J, Riese DJ.

Biochem J. 2012 Apr 1;443(1):133-44. doi: 10.1042/BJ20110921.

4.

ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.

Feroz K, Williams E, Riese DJ 2nd.

Cell Signal. 2002 Sep;14(9):793-8.

PMID:
12034361
5.

Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.

Li Z, Mei Y, Liu X, Zhou M.

Cell Signal. 2007 Mar;19(3):466-71.

PMID:
16978839
6.

Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling.

Wandinger SK, Lahortiga I, Jacobs K, Klammer M, Jordan N, Elschenbroich S, Parade M, Jacoby E, Linders JT, Brehmer D, Cools J, Daub H.

PLoS One. 2016 Jan 8;11(1):e0146100. doi: 10.1371/journal.pone.0146100.

7.

Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.

Fiddes RJ, Janes PW, Sanderson GM, Sivertsen SP, Sutherland RL, Daly RJ.

Cell Growth Differ. 1995 Dec;6(12):1567-77.

8.

Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cells.

Khan IH, Zhao J, Ghosh P, Ziman M, Sweeney C, Kung HJ, Luciw PA.

Assay Drug Dev Technol. 2010 Feb;8(1):27-36. doi: 10.1089/adt.2009.0208.

9.

A quantitative protein interaction network for the ErbB receptors using protein microarrays.

Jones RB, Gordus A, Krall JA, MacBeath G.

Nature. 2006 Jan 12;439(7073):168-74.

PMID:
16273093
10.

Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.

Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK.

Breast Cancer Res Treat. 2006 Jan;95(1):17-27.

11.

ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.

Gordon-Thomson C, Jones J, Mason RS, Moore GP.

Melanoma Res. 2005 Feb;15(1):21-8.

PMID:
15714117
12.

Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.

Mitsui K, Yonezawa M, Tatsuguchi A, Shinji S, Gudis K, Tanaka S, Fujimori S, Sakamoto C.

BMC Cancer. 2014 Nov 22;14:863. doi: 10.1186/1471-2407-14-863.

13.

Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.

Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R, Weickert CS.

Brain Res. 2007 Mar 30;1139:95-109.

PMID:
17280647
14.

Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.

van der Woning SP, van Rotterdam W, Nabuurs SB, Venselaar H, Jacobs-Oomen S, Wingens M, Vriend G, Stortelers C, van Zoelen EJ.

J Biol Chem. 2006 Dec 29;281(52):40033-40.

15.

Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.

Hause RJ Jr, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB.

PLoS One. 2012;7(9):e44471. doi: 10.1371/journal.pone.0044471.

18.

ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.

Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE.

J Biol Chem. 1999 Jun 11;274(24):17209-18.

19.

Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.

Lammering G, Lin PS, Contessa JN, Hampton JL, Valerie K, Schmidt-Ullrich RK.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):775-84.

PMID:
11697324
20.
Items per page

Supplemental Content

Support Center